![](https://www.mad-daily.com/wp-content/uploads/2018/11/allergy-small.jpg)
AUCKLAND, Thursday: Leading pharmaceutical company Menarini Group, working in collaboration with OMD NZ, has used an innovative media strategy for the launch of hayfever treatment Labixten.
The launch campaign used real-time pollen forecast data via MetService Pollen Data API to inform Kiwis when the pollen count was moderate or high in their area.